Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
Anticancer Research
|
March 16, 2004
Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC)
K Link, K Happich, I Schirner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
A V D'Amico, R Whittington, S B Malkowicz, et al.
Oncology
|
February 5, 2003
Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer
A Wein, C Riedel, W Brückl, et al.
Anticancer Research
|
June 25, 2003
Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy
W M Brueckl, C Moesch, T Brabletz, et al.
Anticancer Research
|
February 19, 2002
Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients
W M Brueckl, J M Preuss, A Wein, et al.
JAMA
|
September 28, 1998
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
A V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy
A V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer
A V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2000
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials
A V D'Amico, R Whittington, S B Malkowicz, et al.
Cancer
|
May 20, 1998
Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy
A V D'Amico, A Desjardin, A Chung, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
Anticancer Research
|
March 16, 2004
Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC)
K Link, K Happich, I Schirner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
A V D'Amico, R Whittington, S B Malkowicz, et al.
Oncology
|
February 5, 2003
Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer
A Wein, C Riedel, W Brückl, et al.
Anticancer Research
|
June 25, 2003
Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy
W M Brueckl, C Moesch, T Brabletz, et al.
Anticancer Research
|
February 19, 2002
Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients
W M Brueckl, J M Preuss, A Wein, et al.
JAMA
|
September 28, 1998
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
A V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy
A V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer
A V D'Amico, R Whittington, S B Malkowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2000
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials
A V D'Amico, R Whittington, S B Malkowicz, et al.
Cancer
|
May 20, 1998
Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy
A V D'Amico, A Desjardin, A Chung, et al.
Page
of 11